Corning and SGD Pharma inaugurate glass tubing facility in Telangana for pharma packaging

Corning Incorporated and SGD Pharma have announced the inauguration of a new glass tubing facility in Telangana, which will expand pharmaceutical manufacturing in the region.

The new facility will bring together Corning’s state-of-the-art Velocity® Vial technology and SGD Pharma’s vial-converting expertise, helping address capacity challenges and quality requirements in primary glass packaging.

The new plant will manufacture high-quality Type I borosilicate glass tubing, a critical material used for injectable drug packaging, direct injection delivery systems, diagnostics, and biologics.

By combining SGD Pharma’s vial-converting expertise with Corning’s proprietary Velocity Vial glass-coating technology, the collaboration will enhance vial quality, improve filling-line productivity, and accelerate the delivery of injectable treatments. With tubing production and vial converting co-located, the facility will also deliver efficiencies in sustainability and product quality. 

The new facility will also allow Corning to better serve customers in the region, ensuring faster lead times and strengthening supply chain resilience. This localised manufacturing capacity will also help broaden the adoption of advanced glass tubing solutions for safer and more efficient delivery of critical medicines. 

The joint venture between Corning and SGD Pharma was incorporated in April 2023, followed by a facility groundbreaking in June 2023. Phase one for Velocity Vials production started in March 2024, followed by tubing production in late 2025.